ARAF (P10398) variants and mutations
ARAF (also known as P10398) is a human protein-coding gene encoding a serine/threonine-protein kinase A-Raf protein. It transmits RAS signals to the MEK-ERK pathway and participates in growth and developmental signaling. Activating germline or somatic variants can cause RASopathy phenotypes and have been identified as oncogenic drivers in selected tumors. This analysis covers 1,137 ARAF variants and mutations. Of these, 51% have computational variant effect predictions. Disease context includes cancer, Noonan syndrome, and Costello syndrome. Example ARAF variants include M1?, E2D, and E2G.
Variant analysis overview
- Gene: ARAF
- Protein: P10398
- UniProt accession: P10398
- Organism: Homo sapiens
- Variants analyzed: 1137
- Variant scope: all variants
- Completed: 2026-08-21
Variant and mutation evidence
- Variant composition: 908 unspecified-consequence records; 107 missense variants; 92 synonymous variants; 14 frameshift variants; 5 stop-gained variants; 5 splice-region variants; 5 in-frame deletions; 2 stop lost; 1 substitution
- Prediction scores: 579 variants have prediction scores (51% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: cancer, Noonan syndrome, Costello syndrome, hypertrophic cardiomyopathy, low grade glioma, lymphatic malformation 12, glioma, colorectal adenocarcinoma, lung adenocarcinoma, small cell lung carcinoma, melanoma, lung carcinoma.
Protein structure and variant hotspots
- Protein features: 2 domains; 10 binding sites; 9 post-translational modification sites.
- Structural context: 457 variants have structural context.
- PTM context: 32 variants overlap post-translational modification sites.
- Experimental data: 67 protein positions have experimental scores. Source: binding assays.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable ARAF variants
Examples include M1?, E2D, E2G, P3S, P3P, P4R, P4S, R5Q. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, cosmic curated COSV51692, cosmic curated COSV10879, cosmic curated COSV51693
- E2D (p.Glu2Asp), Ensembl rs2147902422, REVEL 0.14, CADD 17.00
- E2G (p.Glu2Gly), gnomAD X-47562972-A-G, REVEL 0.40, CADD 24.10
- P3S (p.Pro3Ser), Ensembl rs2147902424, REVEL 0.19, CADD 22.10
- P3P (p.Pro3Pro), gnomAD X-47562976-A-C, CADD 11.90
- P4R (p.Pro4Arg), gnomAD rs1376896677, REVEL 0.26, CADD 22.00
- P4S (p.Pro4Ser), gnomAD rs1159713948, REVEL 0.15, CADD 17.80
- R5Q (p.Arg5Gln), cosmic curated COSV51691, TOPMed rs1048525052, gnomAD rs1048525052, REVEL 0.32, CADD 22.80
- R5W (p.Arg5Trp), ExAC rs767772118, TOPMed rs767772118, gnomAD rs767772118, REVEL 0.47, CADD 24.30
- R5R (p.Arg5Arg), gnomAD X-47562980-C-A, CADD 11.70
- G6A (p.Gly6Ala), NCI-TCGA Cosmic COSV5169, cosmic curated COSV51695, REVEL 0.24, CADD 14.70, Variant assessed as somatic; moderate impact.
- G6D (p.Gly6Asp), TOPMed rs2057716739
- G6V (p.Gly6Val), TOPMed rs2057716739
- G6C (p.Gly6Cys), gnomAD X-47562983-G-T, REVEL 0.30, CADD 23.40
- G6G (p.Gly6Gly), gnomAD X-47562985-C-A, CADD 6.54
- P7R (p.Pro7Arg), cosmic curated COSV51695
- P7T (p.Pro7Thr), gnomAD X-47562986-C-A, REVEL 0.21, CADD 16.90
- P7P (p.Pro7Pro), gnomAD X-47562988-C-T, CADD 12.20
- P8L (p.Pro8Leu), rs1453474773, gnomAD X-47562984-GC-G, CADD 16.30
- P8T (p.Pro8Thr), gnomAD X-47562989-C-A, REVEL 0.18, CADD 14.20
- A9D (p.Ala9Asp), Ensembl rs2147902462, REVEL 0.22, CADD 18.30
- A9T (p.Ala9Thr), Ensembl rs2147902459
- A9C (p.Ala9Cys), rs1453474773, gnomAD X-47562984-G-GC, CADD 23.90
- A9G (p.Ala9Gly), gnomAD X-47562993-C-G, REVEL 0.20, CADD 19.10
- A9V (p.Ala9Val), gnomAD X-47562993-C-T, REVEL 0.15, CADD 19.30
- A9A (p.Ala9Ala), gnomAD X-47562994-C-A, CADD 12.10
- N10D (p.Asn10Asp), TOPMed rs2057716852
- N10S (p.Asn10Ser), ExAC rs776073253, TOPMed rs776073253, gnomAD rs776073253, REVEL 0.15, CADD 17.10
- G11V (p.Gly11Val), Ensembl rs2147902475, REVEL 0.44, CADD 20.80
- G11W (p.Gly11Trp), gnomAD X-47562998-G-T, REVEL 0.47, CADD 23.40
- G11G (p.Gly11Gly), rs761115487, gnomAD X-47563000-G-A, CADD 12.10
- A12G (p.Ala12Gly), Ensembl rs62636603
- A12V (p.Ala12Val), Ensembl rs62636603, REVEL 0.29, CADD 19.90
- A12T (p.Ala12Thr), gnomAD X-47563001-G-A, REVEL 0.18, CADD 16.60
- A12S (p.Ala12Ser), gnomAD X-47563001-G-T, REVEL 0.18, CADD 14.80
- A12D (p.Ala12Asp), gnomAD X-47563002-C-A, REVEL 0.45, CADD 18.20
- A12A (p.Ala12Ala), gnomAD X-47563003-C-A, CADD 2.71
- E13D (p.Glu13Asp), Ensembl rs1603042042, REVEL 0.25, CADD 9.46
- E13K (p.Glu13Lys), rs749564014, ClinGen CA10397914, NCI-TCGA Cosmic COSV9928, cosmic curated COSV99283, REVEL 0.29, CADD 19.60, Uncertain significance, not specified
- E13* (p.Glu13Ter), gnomAD X-47563004-G-T, CADD 35.00
- E13E (p.Glu13Glu), rs1603042042, gnomAD X-47563006-G-A, CADD 7.52
- P14L (p.Pro14Leu), cosmic curated COSV51692
- P14S (p.Pro14Ser), Ensembl rs2147902495, REVEL 0.28, CADD 17.10
- P14T (p.Pro14Thr), gnomAD X-47563007-C-A, REVEL 0.24, CADD 15.80
- P14Q (p.Pro14Gln), gnomAD X-47563008-C-A, REVEL 0.38, CADD 22.10
- P14P (p.Pro14Pro), rs1231455467, gnomAD X-47563009-A-G, CADD 1.72
- S15P (p.Ser15Pro), gnomAD X-47563010-T-C, REVEL 0.46, CADD 22.40
- S15T (p.Ser15Thr), gnomAD X-47563010-T-A, REVEL 0.37, CADD 16.40
- S15Y (p.Ser15Tyr), gnomAD X-47563011-C-A, REVEL 0.50, CADD 22.80
- S15F (p.Ser15Phe), gnomAD X-47563011-C-T, REVEL 0.52, CADD 23.10
- S15S (p.Ser15Ser), gnomAD X-47563012-C-A, CADD 9.32
- R16L (p.Arg16Leu), ExAC rs765492001, gnomAD rs765492001, REVEL 0.43, CADD 24.70
- R16Q (p.Arg16Gln), rs765492001, ExAC rs765492001, gnomAD rs765492001, REVEL 0.37, CADD 24.80, Variant assessed as somatic; moderate impact.
- R16W (p.Arg16Trp), 1000Genomes rs201871676, ExAC rs201871676, TOPMed rs201871676, gnomAD rs201871676, REVEL 0.56, CADD 26.20, Uncertain significance, not specified
- R16G (p.Arg16Gly), gnomAD X-47563010-TC-T, CADD 22.80
- R16R (p.Arg16Arg), gnomAD X-47563013-C-A, CADD 11.80
- A17S (p.Ala17Ser), gnomAD rs1235882605, REVEL 0.22, CADD 9.39
- A17T (p.Ala17Thr), gnomAD rs1235882605, REVEL 0.24, CADD 9.55
- A17Q (p.Ala17Gln), gnomAD X-47563013-CG-C, CADD 24.80
- A17V (p.Ala17Val), gnomAD X-47563017-C-T, REVEL 0.22, CADD 21.10
- A17E (p.Ala17Glu), gnomAD X-47563017-C-A, REVEL 0.36, CADD 19.50
- V18L (p.Val18Leu), ExAC rs750598176, TOPMed rs750598176, gnomAD rs750598176, REVEL 0.27, CADD 16.00
- V18M (p.Val18Met), ExAC rs750598176, TOPMed rs750598176, gnomAD rs750598176
- V18V (p.Val18Val), gnomAD X-47563021-G-A, CADD 9.92
- G19D (p.Gly19Asp), cosmic curated COSV10961, Ensembl rs2147902510, REVEL 0.54, CADD 23.80
- G19A (p.Gly19Ala), gnomAD X-47563020-TG-T, CADD 23.60
- G19C (p.Gly19Cys), gnomAD X-47563022-G-T, REVEL 0.56, CADD 25.80
- G19S (p.Gly19Ser), gnomAD X-47563022-G-A, REVEL 0.34, CADD 22.90
- G19V (p.Gly19Val), gnomAD X-47563023-G-T, REVEL 0.61, CADD 25.10
- G19G (p.Gly19Gly), gnomAD X-47563024-C-A, CADD 9.92
- T20I (p.Thr20Ile), cosmic curated COSV10500
- T20A (p.Thr20Ala), gnomAD X-47563025-A-G, REVEL 0.65, CADD 23.80
- T20T (p.Thr20Thr), rs201204685, gnomAD X-47563027-C-T, CADD 4.13
- V21D (p.Val21Asp), Ensembl rs2147902522
- V21I (p.Val21Ile), cosmic curated COSV51695, ExAC rs779656098, gnomAD rs779656098, REVEL 0.25, CADD 16.70
- V21F (p.Val21Phe), gnomAD X-47563028-G-T, REVEL 0.61, CADD 25.40
- V21A (p.Val21Ala), gnomAD X-47563029-T-C, REVEL 0.69, CADD 25.60
- K22I (p.Lys22Ile), ExAC rs746987091, gnomAD rs746987091, REVEL 0.61, CADD 27.10
- K22R (p.Lys22Arg), gnomAD X-47563032-A-G, REVEL 0.29, CADD 18.40
- V23L (p.Val23Leu), NCI-TCGA Cosmic COSV9928, cosmic curated COSV99283, REVEL 0.79, CADD 26.10, Variant assessed as somatic; moderate impact.
- V23I (p.Val23Ile), gnomAD X-47563034-G-A, REVEL 0.64, CADD 24.10
- V23V (p.Val23Val), gnomAD X-47563036-A-G, CADD 9.78
- Y24H (p.Tyr24His), gnomAD X-47563037-T-C, REVEL 0.68, CADD 23.50
- Y24C (p.Tyr24Cys), gnomAD X-47563038-A-G, REVEL 0.78, CADD 25.90
- Y24Y (p.Tyr24Tyr), gnomAD X-47563039-C-T, CADD 10.20
- L25Q (p.Leu25Gln), gnomAD rs1431755155, REVEL 0.92, CADD 26.90
- L25M (p.Leu25Met), gnomAD X-47563040-C-A, REVEL 0.69, CADD 23.80
- L25L (p.Leu25Leu), gnomAD X-47563042-G-T, CADD 10.50
- P26S (p.Pro26Ser), gnomAD X-47563043-C-T, REVEL 0.90, CADD 25.20
- P26T (p.Pro26Thr), gnomAD X-47563043-C-A, REVEL 0.91, CADD 24.80
- P26L (p.Pro26Leu), gnomAD X-47563044-C-T, REVEL 0.92, CADD 26.80
- P26P (p.Pro26Pro), gnomAD X-47563045-C-A, CADD 11.00
- N27N (p.Asn27Asn), gnomAD X-47563048-C-T, CADD 12.70
- N27K (p.Asn27Lys), gnomAD X-47563048-C-A, REVEL 0.70, CADD 24.80
- K28T (p.Lys28Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- K28K (p.Lys28Lys), rs1470395324, gnomAD X-47563051-G-A, CADD 11.50
- Q29P (p.Gln29Pro), cosmic curated COSV51695
- Q29* (p.Gln29Ter), gnomAD X-47563052-C-T, CADD 45.00
- Q29Q (p.Gln29Gln), rs143620653, gnomAD X-47563054-A-G, CADD 10.40
- R30C (p.Arg30Cys), cosmic curated COSV51695, REVEL 0.73, CADD 33.00
- R30H (p.Arg30His), rs1398289359, NCI-TCGA Cosmic COSV5169, cosmic curated COSV51693, gnomAD rs1398289359, REVEL 0.86, CADD 29.00, Variant assessed as somatic; moderate impact.
- R30L (p.Arg30Leu), gnomAD rs1398289359, REVEL 0.95, CADD 32.00
- R30G (p.Arg30Gly), gnomAD X-47563055-C-G, REVEL 0.82, CADD 32.00
- R30R (p.Arg30Arg), gnomAD X-47563057-C-A, CADD 12.80
- T31K (p.Thr31Lys), cosmic curated COSV51692, REVEL 0.88, CADD 27.60
- T31M (p.Thr31Met), gnomAD rs1444450941, REVEL 0.81, CADD 25.80
- T31R (p.Thr31Arg), gnomAD rs1444450941
- T31T (p.Thr31Thr), rs368665293, gnomAD X-47563060-G-T, CADD 7.42
- V32=, NCI-TCGA TCGA novel, Variant assessed as somatic; low impact.
- V32V (p.Val32Val), gnomAD X-47563063-G-T, CADD 24.40
- V33V (p.Val33Val), rs1214674508, gnomAD X-47563228-G-A, CADD 10.60
- T34I (p.Thr34Ile), TOPMed rs975645936, gnomAD rs975645936, REVEL 0.33, CADD 22.50
- T34S (p.Thr34Ser), TOPMed rs975645936, gnomAD rs975645936
- V35D (p.Val35Asp), cosmic curated COSV51691
- V35I (p.Val35Ile), gnomAD X-47563232-G-A, REVEL 0.54, CADD 23.60
- V35V (p.Val35Val), gnomAD X-47563234-C-A, CADD 10.80
- R36G (p.Arg36Gly), TOPMed rs1283082877
- R36Q (p.Arg36Gln), cosmic curated COSV10439, REVEL 0.86, CADD 27.80
- R36W (p.Arg36Trp), TOPMed rs1283082877, REVEL 0.86, CADD 28.00
- R36R (p.Arg36Arg), gnomAD X-47563237-G-C, CADD 11.90
- D37G (p.Asp37Gly), gnomAD X-47563239-A-G, REVEL 0.35, CADD 23.00
- G38C (p.Gly38Cys), cosmic curated COSV51692
- G38R (p.Gly38Arg), TOPMed rs1210265001, gnomAD rs1210265001, REVEL 0.94, CADD 27.80
- G38G (p.Gly38Gly), gnomAD X-47563243-C-T, CADD 12.10
- M39K (p.Met39Lys), cosmic curated COSV51693
- M39V (p.Met39Val), ExAC rs781331960, gnomAD rs781331960, REVEL 0.51, CADD 17.90
- M39I (p.Met39Ile), gnomAD X-47563246-G-A, REVEL 0.60, CADD 22.50
- S40T (p.Ser40Thr), gnomAD X-47563248-G-C, REVEL 0.26, CADD 16.70
- S40S (p.Ser40Ser), rs151030523, gnomAD X-47563249-T-C, CADD 12.90
- V41I (p.Val41Ile), NCI-TCGA Cosmic COSV9928, cosmic curated COSV99283, REVEL 0.40, CADD 23.20, Variant assessed as somatic; moderate impact.
- Y42C (p.Tyr42Cys), gnomAD rs1292396776, REVEL 0.57, CADD 23.80
- Y42Y (p.Tyr42Tyr), rs755693043, gnomAD X-47563255-C-T, CADD 8.87
- D43E (p.Asp43Glu), cosmic curated COSV10586
- D43N (p.Asp43Asn), rs1569319031, NCI-TCGA Cosmic COSV5169, cosmic curated COSV51691, Ensembl rs1569319031, REVEL 0.38, CADD 24.30, Variant assessed as somatic; moderate impact.
- S44F (p.Ser44Phe), Ensembl rs11551157
- S44S (p.Ser44Ser), gnomAD X-47563261-T-C, CADD 12.60
- L45V (p.Leu45Val), cosmic curated COSV10461
- D46N (p.Asp46Asn), cosmic curated COSV10640, REVEL 0.38, CADD 23.60
- A48A (p.Ala48Ala), rs1303122276, gnomAD X-47563273-C-T, CADD 10.70
- L49P (p.Leu49Pro), cosmic curated COSV51692
- L49L (p.Leu49Leu), rs1263646628, gnomAD X-47563274-C-T, CADD 11.60
- K50N (p.Lys50Asn), cosmic curated COSV10586
- V51A (p.Val51Ala), TOPMed rs922510408, gnomAD rs922510408, REVEL 0.75, CADD 24.30
- V51L (p.Val51Leu), gnomAD rs1214099265, REVEL 0.39, CADD 21.70
- R52L (p.Arg52Leu), cosmic curated COSV99283
- R52Q (p.Arg52Gln), cosmic curated COSV10879, ESP rs140920401, gnomAD rs140920401, REVEL 0.77, CADD 29.00
- R52W (p.Arg52Trp), cosmic curated COSV51693, Ensembl rs2147902794, REVEL 0.79, CADD 25.60
- G53D (p.Gly53Asp), cosmic curated COSV51695, Ensembl rs2147902800
- G53S (p.Gly53Ser), ExAC rs777093232, gnomAD rs777093232, REVEL 0.83, CADD 27.20
- G53V (p.Gly53Val), gnomAD X-47563283-CG-C, CADD 30.00
- L54V (p.Leu54Val), NCI-TCGA Cosmic COSV9928, cosmic curated COSV99283, Variant assessed as somatic; moderate impact.
- L54L (p.Leu54Leu), rs748995528, gnomAD X-47563291-A-G, CADD 11.50
- Q56K (p.Gln56Lys), cosmic curated COSV10461, Ensembl rs2147902804
- Q56Q (p.Gln56Gln), gnomAD X-47563297-G-A, CADD 8.51
- D57E (p.Asp57Glu), cosmic curated COSV51694
- D57H (p.Asp57His), cosmic curated COSV51693
- C58Y (p.Cys58Tyr), Ensembl rs2147902807
- C59F (p.Cys59Phe), cosmic curated COSV51694, Uncertain significance, not specified
- C59Y (p.Cys59Tyr), Ensembl rs2147902815
- V60M (p.Val60Met), gnomAD X-47563307-G-A, REVEL 0.59, CADD 26.40
- V60A (p.Val60Ala), gnomAD X-47563308-T-C, REVEL 0.24, CADD 18.40
- R63Q (p.Arg63Gln), rs1413219188, NCI-TCGA Cosmic COSV5169, cosmic curated COSV51695, TOPMed rs1413219188, REVEL 0.74, CADD 28.50, Variant assessed as somatic; moderate impact.
- R63del (p.Arg63del), gnomAD X-47563315-CCGA-C, CADD 21.30
- R63* (p.Arg63Ter), gnomAD X-47563316-C-T, CADD 35.00
- L64F (p.Leu64Phe), gnomAD X-47563319-C-T, REVEL 0.71, CADD 23.60
- L64L (p.Leu64Leu), rs1366041820, gnomAD X-47563321-C-T, CADD 12.40
- I65V (p.Ile65Val), cosmic curated COSV51693
- I65del (p.Ile65del), gnomAD X-47563319-CTCA-C, CADD 19.40
- K66N (p.Lys66Asn), cosmic curated COSV51694
- K66R (p.Lys66Arg), gnomAD X-47563326-A-G, REVEL 0.23, CADD 21.50
- G67R (p.Gly67Arg), cosmic curated COSV10500
- R68* (p.Arg68Ter), NCI-TCGA Cosmic COSV5169, cosmic curated COSV51692, CADD 33.00, Variant assessed as somatic; high impact.
- R68L (p.Arg68Leu), gnomAD rs1410667957, REVEL 0.57, CADD 24.00
- R68P (p.Arg68Pro), cosmic curated COSV51693
- R68Q (p.Arg68Gln), cosmic curated COSV51695, gnomAD rs1410667957, REVEL 0.34, CADD 23.60
- R68R (p.Arg68Arg), rs2147903792, gnomAD X-47564798-C-A, CADD 12.30
- K69R (p.Lys69Arg), TOPMed rs958658251
- K69K (p.Lys69Lys), rs369107922, gnomAD X-47564803-G-A, CADD 7.43
- T70M (p.Thr70Met), rs199527940, NCI-TCGA Cosmic COSV5169, cosmic curated COSV51691, 1000Genomes rs199527940, REVEL 0.35, CADD 21.30, Variant assessed as somatic; moderate impact.
- T70K (p.Thr70Lys), gnomAD X-47564805-C-A, REVEL 0.32, CADD 12.10
Public ARAF analysis runs
- ARAF analysis run — ARAF (1,137 variants) — completed 2026-08-21